Real-world evaluation of weight loss in patients with T2DM treated with canagliflozin (CANA) – An electronic health-record (EHR)-based study. (October 2016) - Lefebvre, Patrick; Chow, Wing; Pilon, Dominic; Emond, Bruno; Lafeuille, Marie-Hélène; Pfeifer, Michael; Rupnow, Marcia; Duh, Mei Sheng; Fegade, Mayuresh